Fair Value Distribution — percentile bands
81.0% of simulations place fair value above current price
WHAT IS PRICED IN
Revenue-Based Reverse DCF
-1.0%/yr
±10.5% · revenue growth to justify current price
FCF-Based Reverse DCF
-7.7%/yr
±3.6% · FCF growth to justify current price
THE GAP
Market pricing margin expansion or capex normalization
KEY VALUE DRIVERS
Spearman correlation — what moves this valuation most
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally.
No Eagle analysis yet. Request a full review including conviction score, bull/bear cases, and thesis.
No analysis yet
No analysis yet
UNH's Q3 2025 filing reveals the worst earnings reset in the company's modern history. MCR hit 89.9% in Q3 (+470bps YoY), earnings from operations collapsed 50% to .3B, and EPS fell to .59 from .51. T...